Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Glioma 4Glioblastoma 2Parathyroid Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Neoplasms, Neuroepithelial 1Multiple Endocrine Neoplasia 1Hypoglycemia 1Hyperparathyroidism 1Hypercalcemia 1Gliosarcoma 1Ependymoma 1Brain Neoplasms 1Astrocytoma 1

Interventions

parathyroid hormone-related peptide (1-36) 1gallium Ga 68 dotatate 1fluorodopa F 18 1etelcalcetide hydrochloride 1Saline Solution 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Hyperparathyroidism × fluorodopa F 18 × Clear all
NCT00001277 2022-06-07

Studies of Elevated Parathyroid Activity

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
1,553 enrolled 8 charts
EndocrineHead & Neck

Hypercalcemia, Hyperparathyroidism, Hypoglycemia, Multiple Endocrine Neoplasia, Parathyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡